- Home
- ACI vs SNN Comparison
ACI vs SNN Comparison
Compare ACI & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACI
- SNN
- Stock Information
- Founded
- ACI 1860
- SNN 1856
- Country
- ACI United States
- SNN United Kingdom
- Employees
- ACI N/A
- SNN N/A
- Industry
- ACI Food Chains
- SNN Industrial Specialties
- Sector
- ACI Consumer Staples
- SNN Health Care
- Exchange
- ACI Nasdaq
- SNN Nasdaq
- Market Cap
- ACI 12.8B
- SNN 12.7B
- IPO Year
- ACI 2020
- SNN 1999
- Fundamental
- Price
- ACI $21.27
- SNN $30.12
- Analyst Decision
- ACI Buy
- SNN Hold
- Analyst Count
- ACI 12
- SNN 3
- Target Price
- ACI $24.42
- SNN $27.50
- AVG Volume (30 Days)
- ACI 4.0M
- SNN 609.2K
- Earning Date
- ACI 07-22-2025
- SNN 07-31-2025
- Dividend Yield
- ACI 2.83%
- SNN 2.48%
- EPS Growth
- ACI N/A
- SNN 56.15
- EPS
- ACI 1.64
- SNN 0.47
- Revenue
- ACI $80,390,900,000.00
- SNN $5,810,000,000.00
- Revenue This Year
- ACI $4.55
- SNN $6.87
- Revenue Next Year
- ACI $0.69
- SNN $5.19
- P/E Ratio
- ACI $12.93
- SNN $32.23
- Revenue Growth
- ACI 1.46
- SNN 4.70
- 52 Week Low
- ACI $17.00
- SNN $23.69
- 52 Week High
- ACI $23.20
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- ACI 40.55
- SNN 65.75
- Support Level
- ACI $20.99
- SNN $29.84
- Resistance Level
- ACI $21.70
- SNN $29.27
- Average True Range (ATR)
- ACI 0.39
- SNN 0.30
- MACD
- ACI -0.10
- SNN 0.07
- Stochastic Oscillator
- ACI 21.03
- SNN 87.10
About ACI Albertsons Companies Inc.
Albertsons is the second-largest supermarket operator in the United States with about 2,300 stores across a variety of banners. Around 80% of the firm's sales comes from nonperishable and fresh food, of which 25% comes from its portfolio of private brands. The company operates fuel centers at about 20% of its store locations and pharmacies at 75%. Albertsons went public in 2020 following years of ownership under private equity firm Cerberus Capital Management, which still owns about a fourth of the outstanding shares.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.